Safely Innovating with Sensitive Data

Safely Innovating with Sensitive Data

Safely Innovating with Sensitive Data

Date of Event: November 3, 2021

Location: LinkedIn Live

If you’re looking to safely use and share your organization’s sensitive data while earning trust from stakeholders, this LinkedIn Live Event is for you.

Join Sarah Lyons, Head of Privacy Analytics, in a fireside chat with Len Usvyat, Vice President, Applied Data Science, Biostatistics, and Epidemiology at Fresenius Medical Care. They’ll be discussing ways to cut through the complexities of the data privacy landscape to help you move forward with confidence when leveraging data derived from information about people.

When the EU’s General Data Protection Regulation (GDPR) came into effect, Fresenius Medical Care and its affiliates were stuck sitting on insight-rich data, wondering how they could make the best use of it to improve renal patient care – while protecting privacy.

As founding members of the international, non-profit MONitoring Dialysis Outcomes (MONDO) consortium, Renal Research Institute and its partners, such as Fresenius Medical Care, found a solution to keep the vital data-sharing operation going.

Join us to find out how they did it and what it could mean for your organization. You’ll hear directly from an executive who’s leveraging sensitive data safely and responsibly to deliver significant benefits to business and society.

“Without Privacy Analytics, we would not have been able to continue with the initiative”
— Len Usvyat, Vice President, Applied Data Science, Biostatistics, and Epidemiology at Fresenius Medical Care

Event registration is now closed.

Presenter(s)

Len Usvyat is the Vice President of Applied Data Science, Biostatistics, and Epidemiology for Fresenius Medical Care.

Len Usvyat

Vice President, Applied Data Science, Biostatistics, and Epidemiology, Fresenius Medical Care

Archiving / Destroying

Are you unleashing the full value of data you retain?

Your Challenges

Do you need help...

OUR SOLUTION

Value Retention

Client Success

Client: Comcast

Situation: California’s Consumer Privacy Act inspired Comcast to evolve the way in which they protect the privacy of customers who consent to share personal information with them.

Evaluating

Are you achieving intended outcomes from data?

Your Challenge

Do you need help...

OUR SOLUTION

Unbiased Results

Client Success

Client: Integrate.ai

Situation: Integrate.ai’s AI-powered tech helps clients improve their online experience by sharing signals about website visitor intent. They wanted to ensure privacy remained fully protected within the machine learning / AI context that produces these signals.

Accessing

Do the right people have the right data?

Your Challenges

Do you need help...

OUR SOLUTION

Usable and Reusable Data

Client Success

Client: Novartis

Situation: Novartis’ digital transformation in drug R&D drives their need to maximize value from vast stores of clinical study data for critical internal research enabled by their data42 platform.

 

Maintaining

Are you empowering people to safely leverage trusted data?

Your Challenges

Do you need help...

OUR SOLUTION

Security / compliance efficiency

CLIENT SUCCESS

Client: ASCO’s CancerLinQ

Situation: CancerLinQ™, a subsidiary of American Society of Clinical Oncology, is a rapid learning healthcare system that helps oncologists aggregate and analyze data on cancer patients to improve care. To achieve this goal, they must de-identify patient data provided by subscribing practices across the U.S.

 

Acquiring / Collecting

Are you acquiring the right data? Do you have appropriate consent?

Your Challenge

Do you need help...

OUR SOLUTIONS

Consent / Contracting strategy

Client Success

Client: IQVIA

Situation: Needed to ensure the primary market research process was fully compliant with internal policies and regulations such as GDPR. 

 

Planning

Are You Effectively Planning for Success?

Your Challenges

Do you need help...

OUR SOLUTION

Build privacy in by design

Client Success

Client: Nuance

Situation: Needed to enable AI-driven product innovation with a defensible governance program for the safe and responsible use
of voice-to-text data under Shrems II.

 

Join the next 5 Safes Data Privacy webinar

This course runs on the 2nd Wednesday of every month, at 11 a.m. ET (45 mins). Click the button to register and select the date that works best for you.